Myriad Genetics, Inc. (MYGN)

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $1.56 billion as of November 4, 2024. Its market cap has increased by 30.21% in one year.

• Market Cap: 1.56B
• Enterprise Value: 1.68B
• 1-Year Change: 30.21%
• Ranking: #2091
• Category: Small-Cap
• Stock Price: $17.21

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $1.56B, an increase of 1,427.88%. That is a compound annual growth rate of 11.08%.

Market Cap History

Date	Market Cap	% Change
Nov 1, 2024	1.63B	3.85%
Dec 29, 2023	1.57B	33.81%
Dec 30, 2022	1.18B	-46.65%
Dec 31, 2021	2.20B	48.19%
Dec 31, 2020	1.49B	-26.57%
Dec 31, 2019	2.03B	-6.80%
Dec 31, 2018	2.17B	-8.61%
Dec 29, 2017	2.38B	108.51%
Dec 30, 2016	1.14B	-62.13%
Dec 31, 2015	3.01B	21.14%
Dec 31, 2014	2.49B	58.51%
Dec 31, 2013	1.57B	-29.30%
Dec 31, 2012	2.22B	25.03%
Dec 30, 2011	1.77B	-15.91%
Dec 31, 2010	2.11B	-15.93%
Dec 31, 2009	2.51B	-18.54%
Dec 31, 2008	3.08B	50.95%
Dec 31, 2007	2.04B	64.00%
Dec 29, 2006	1.24B	93.29%
Dec 30, 2005	643.90M	-6.71%
Dec 31, 2004	690.20M	98.11%
Dec 31, 2003	348.40M	-0.17%
Dec 31, 2002	349.00M	-71.84%
Dec 31, 2001	1.24B	-34.15%
Dec 29, 2000	1.88B	304.51%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Nurix Therapeutics	1.73B
Spyre Therapeutics	1.73B
Celldex Therapeutics	1.70B
Viridian Therapeutics	1.70B
Certara	1.65B
AtriCure	1.63B
Kiniksa Pharmaceuticals International,	1.62B
Ocular Therapeutix	1.62B